Stock Region Watchlist
Monday Watchlist: NFLX, SLNO & MSTR
Monday Watchlist: NFLX, SLNO & MSTR
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The following newsletter is for informational and educational purposes only. We are not certified financial advisors. All opinions expressed are our own. Please do your own research and consult a professional before making any investment decisions.
A brand new week is here, and the market is already presenting some fascinating setups. Grab a morning coffee, settle in, and dive straight into the watchlist for April 6, 2026. Keep a close eye on a few big movers today—the setups look absolutely wild.
Here is what we are watching.
🍿 Netflix ($NFLX): Flexing Its Pricing Power
Netflix is showing some serious muscle this morning. Rosenblatt just bumped their price target up to $96, pointing directly to the company’s aggressive stock buyback strategies and climbing financial estimates.
But here’s what stands out: Netflix is rolling out another price hike in 2026. While higher subscription fees may cause some to rethink their streaming budget, this move demonstrates strong pricing power and confidence in continued demand. The company clearly believes consumers will support the new rates.
What to watch:
Earnings Date: Keep April 16 circled on your calendar. They report Q1 results.
The Expectations: Wall Street is looking for $12.157 billion in revenue (a 15.3% year-over-year jump) and a massive 32.1% operating margin.
Outlook: Reaching those margins could propel momentum nicely through the spring.
🧬 Soleno Therapeutics ($SLNO): The Acquisition Pop
If you woke up and saw Soleno’s chart, you probably rubbed your eyes a few times. Neurocrine Biosciences just announced they are buying Soleno for $2.9 billion in cash. That values the stock at $53 per share, sending it soaring nearly 40% right out of the gate.
Honestly, seeing a 40% jump is the exact kind of action that makes market watching so fun. This acquisition makes perfect sense. Neurocrine wants Soleno’s incredibly valuable portfolio, especially their treatments for rare conditions like Prader-Willi syndrome.
Short-term levels to watch:
Upside: Above $54.95
Downside: Below $47.58
🪙 Strategy ($MSTR): Riding the Crypto Rollercoaster
You cannot talk about Strategy without talking about Bitcoin. The company just dropped an update on its crypto holdings, reporting a Q1 unrealized digital asset loss of $14.46 billion alongside some valuation allowances.
The company also stayed busy selling stock. Between April 1 and April 5, over 1 million shares of STRC stock were unloaded, bringing in $102.6 million in net proceeds. Despite broader weakness seen in the Bitcoin market, $MSTR is holding steady around $318. Their resilience in the face of massive crypto volatility continues to impress, remaining fully committed to their chosen strategy.
Short-term levels to watch:
Upside: Above $126.03
Downside: Below $119.83
What are you watching this week? Hit reply and let us know which of these three tickers you think has the best setup. We love hearing your takes!
Stay green out there, and trade smart.
Disclaimer: Trading stocks and cryptocurrencies involves significant risk and can result in the loss of your invested capital. The personal opinions shared in this newsletter are just that—personal opinions. They do not constitute financial advice. Always perform your due diligence.